Avanos Medical (NYSE:AVNS) reported quarterly earnings results on February 24, 2026 that exceeded analyst expectations.
The Healthcare company reported earnings per share of $0.29, beating the consensus estimate of $0.25 by $0.04 per share. Revenue came in at $180.9M, beating the estimate of $175.3M.
Avanos Medical's stock moved following the earnings release. The stock currently trades at $14.01 with a market capitalization of $549.3M.


